Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes

Jenny N. Poynter, Michaela Richardson, Cindy K. Blair, Michelle A. Roesler, Betsy A. Hirsch, Phuong Nguyen, Adina Cioc, Erica Warlick, James R Cerhan, Julie A. Ross

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Overweight and obesity are known risk factors for a number of cancers, with recent evidence suggesting that risk of hematologic cancer is also increased in obese individuals. We evaluated associations between body mass index (BMI) at differing time points during the life course in population-based case control studies of acute myeloid leukemia (AML) and myelodysplatic syndromes (MDS). Methods: Cases were identified by the Minnesota Cancer Surveillance System. Controls were identified through the Minnesota State driver's license/identification card list. BMI was calculated using self-reported height and weight at ages 18, 35, and 50 years and two years prior to interview, and categorized as normal (18.5-25 kg/m2), overweight (25-29.9 kg/m2), obese class I (30-34.9 kg/m2), and obese class II/III (35+ kg/m2). All analyses were stratified by sex. Unconditional logistic regression was used to calculate odds ratios and 95% confidence intervals. Results: We included 420 AML cases, 265 MDS cases and 1388 controls. Obesity two years prior to diagnosis was associated with AML in both males and females (OR = 2.22, 95% CI 1.28, 3.85 and OR = 1.85, 95% CI 1.08, 3.15 for BMI ≥ 35 vs. BMI 18.5-24.9, respectively). In contrast, associations between obesity and MDS were observed only in females. Weight change in adulthood was not consistently associated with either outcome. Conclusion: Our results extend the emerging literature suggesting that obesity is a risk factor for hematologic malignancy and provide evidence that that the association remains regardless of timing of obesity. Obesity in adulthood is a modifiable risk factor for both MDS and AML.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalCancer Epidemiology
Volume40
DOIs
StatePublished - Feb 1 2016

Fingerprint

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Obesity
Body Mass Index
Weights and Measures
Neoplasms
Hematologic Neoplasms
Licensure
Case-Control Studies
Logistic Models
Odds Ratio
Confidence Intervals
Interviews
Population

Keywords

  • AML
  • Epidemiology
  • Myelodysplastic syndromes
  • Obesity

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Epidemiology

Cite this

Poynter, J. N., Richardson, M., Blair, C. K., Roesler, M. A., Hirsch, B. A., Nguyen, P., ... Ross, J. A. (2016). Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. Cancer Epidemiology, 40, 134-140. https://doi.org/10.1016/j.canep.2015.12.005

Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. / Poynter, Jenny N.; Richardson, Michaela; Blair, Cindy K.; Roesler, Michelle A.; Hirsch, Betsy A.; Nguyen, Phuong; Cioc, Adina; Warlick, Erica; Cerhan, James R; Ross, Julie A.

In: Cancer Epidemiology, Vol. 40, 01.02.2016, p. 134-140.

Research output: Contribution to journalArticle

Poynter, JN, Richardson, M, Blair, CK, Roesler, MA, Hirsch, BA, Nguyen, P, Cioc, A, Warlick, E, Cerhan, JR & Ross, JA 2016, 'Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes', Cancer Epidemiology, vol. 40, pp. 134-140. https://doi.org/10.1016/j.canep.2015.12.005
Poynter, Jenny N. ; Richardson, Michaela ; Blair, Cindy K. ; Roesler, Michelle A. ; Hirsch, Betsy A. ; Nguyen, Phuong ; Cioc, Adina ; Warlick, Erica ; Cerhan, James R ; Ross, Julie A. / Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. In: Cancer Epidemiology. 2016 ; Vol. 40. pp. 134-140.
@article{acbf84bda7c74d4a85d9b75fcc044e14,
title = "Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes",
abstract = "Background: Overweight and obesity are known risk factors for a number of cancers, with recent evidence suggesting that risk of hematologic cancer is also increased in obese individuals. We evaluated associations between body mass index (BMI) at differing time points during the life course in population-based case control studies of acute myeloid leukemia (AML) and myelodysplatic syndromes (MDS). Methods: Cases were identified by the Minnesota Cancer Surveillance System. Controls were identified through the Minnesota State driver's license/identification card list. BMI was calculated using self-reported height and weight at ages 18, 35, and 50 years and two years prior to interview, and categorized as normal (18.5-25 kg/m2), overweight (25-29.9 kg/m2), obese class I (30-34.9 kg/m2), and obese class II/III (35+ kg/m2). All analyses were stratified by sex. Unconditional logistic regression was used to calculate odds ratios and 95{\%} confidence intervals. Results: We included 420 AML cases, 265 MDS cases and 1388 controls. Obesity two years prior to diagnosis was associated with AML in both males and females (OR = 2.22, 95{\%} CI 1.28, 3.85 and OR = 1.85, 95{\%} CI 1.08, 3.15 for BMI ≥ 35 vs. BMI 18.5-24.9, respectively). In contrast, associations between obesity and MDS were observed only in females. Weight change in adulthood was not consistently associated with either outcome. Conclusion: Our results extend the emerging literature suggesting that obesity is a risk factor for hematologic malignancy and provide evidence that that the association remains regardless of timing of obesity. Obesity in adulthood is a modifiable risk factor for both MDS and AML.",
keywords = "AML, Epidemiology, Myelodysplastic syndromes, Obesity",
author = "Poynter, {Jenny N.} and Michaela Richardson and Blair, {Cindy K.} and Roesler, {Michelle A.} and Hirsch, {Betsy A.} and Phuong Nguyen and Adina Cioc and Erica Warlick and Cerhan, {James R} and Ross, {Julie A.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.canep.2015.12.005",
language = "English (US)",
volume = "40",
pages = "134--140",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes

AU - Poynter, Jenny N.

AU - Richardson, Michaela

AU - Blair, Cindy K.

AU - Roesler, Michelle A.

AU - Hirsch, Betsy A.

AU - Nguyen, Phuong

AU - Cioc, Adina

AU - Warlick, Erica

AU - Cerhan, James R

AU - Ross, Julie A.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background: Overweight and obesity are known risk factors for a number of cancers, with recent evidence suggesting that risk of hematologic cancer is also increased in obese individuals. We evaluated associations between body mass index (BMI) at differing time points during the life course in population-based case control studies of acute myeloid leukemia (AML) and myelodysplatic syndromes (MDS). Methods: Cases were identified by the Minnesota Cancer Surveillance System. Controls were identified through the Minnesota State driver's license/identification card list. BMI was calculated using self-reported height and weight at ages 18, 35, and 50 years and two years prior to interview, and categorized as normal (18.5-25 kg/m2), overweight (25-29.9 kg/m2), obese class I (30-34.9 kg/m2), and obese class II/III (35+ kg/m2). All analyses were stratified by sex. Unconditional logistic regression was used to calculate odds ratios and 95% confidence intervals. Results: We included 420 AML cases, 265 MDS cases and 1388 controls. Obesity two years prior to diagnosis was associated with AML in both males and females (OR = 2.22, 95% CI 1.28, 3.85 and OR = 1.85, 95% CI 1.08, 3.15 for BMI ≥ 35 vs. BMI 18.5-24.9, respectively). In contrast, associations between obesity and MDS were observed only in females. Weight change in adulthood was not consistently associated with either outcome. Conclusion: Our results extend the emerging literature suggesting that obesity is a risk factor for hematologic malignancy and provide evidence that that the association remains regardless of timing of obesity. Obesity in adulthood is a modifiable risk factor for both MDS and AML.

AB - Background: Overweight and obesity are known risk factors for a number of cancers, with recent evidence suggesting that risk of hematologic cancer is also increased in obese individuals. We evaluated associations between body mass index (BMI) at differing time points during the life course in population-based case control studies of acute myeloid leukemia (AML) and myelodysplatic syndromes (MDS). Methods: Cases were identified by the Minnesota Cancer Surveillance System. Controls were identified through the Minnesota State driver's license/identification card list. BMI was calculated using self-reported height and weight at ages 18, 35, and 50 years and two years prior to interview, and categorized as normal (18.5-25 kg/m2), overweight (25-29.9 kg/m2), obese class I (30-34.9 kg/m2), and obese class II/III (35+ kg/m2). All analyses were stratified by sex. Unconditional logistic regression was used to calculate odds ratios and 95% confidence intervals. Results: We included 420 AML cases, 265 MDS cases and 1388 controls. Obesity two years prior to diagnosis was associated with AML in both males and females (OR = 2.22, 95% CI 1.28, 3.85 and OR = 1.85, 95% CI 1.08, 3.15 for BMI ≥ 35 vs. BMI 18.5-24.9, respectively). In contrast, associations between obesity and MDS were observed only in females. Weight change in adulthood was not consistently associated with either outcome. Conclusion: Our results extend the emerging literature suggesting that obesity is a risk factor for hematologic malignancy and provide evidence that that the association remains regardless of timing of obesity. Obesity in adulthood is a modifiable risk factor for both MDS and AML.

KW - AML

KW - Epidemiology

KW - Myelodysplastic syndromes

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84960080672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960080672&partnerID=8YFLogxK

U2 - 10.1016/j.canep.2015.12.005

DO - 10.1016/j.canep.2015.12.005

M3 - Article

C2 - 26720913

AN - SCOPUS:84960080672

VL - 40

SP - 134

EP - 140

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

ER -